World's Best Scientists 2026 revealed!
Nigel J. Temperton

Nigel J. Temperton

D-Index & Metrics

Microbiology

D-Index
53
Citations
14021
World Ranking
4047
National Ranking
357

Nigel J. Temperton publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Nigel J. Temperton sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 171 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Nigel J. Temperton D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Nigel J. Temperton sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 53 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Nigel J. Temperton is affiliated with the Medway School of Pharmacy in the United Kingdom. Their research specializes primarily in Medicine, with a significant focus on Infectious Diseases, Epidemiology, and Immunology. Their work spans multiple interconnected fields including Animal Science and Zoology, as well as Molecular Biology.

Their main research topics cover a range of viral infections and epidemiological studies, specifically:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • Animal Virus Infections Studies
  • SARS-CoV-2 detection and testing
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology

Temperton has contributed to numerous scientific papers in respected publication venues. Frequent venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Nature Communications
  • SSRN Electronic Journal
  • Scientific Reports

Their recent papers of note include:

  • Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans, 2020, Nature Microbiology
  • SARS-CoV-2 evolution during treatment of chronic infection, 2021, Nature
  • Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum, 2022, Cell
  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum, 2021, Cell
  • The antigenic anatomy of SARS-CoV-2 receptor binding domain, 2021, Cell

In collaborative efforts, Nigel J. Temperton frequently coauthors with several researchers, indicating a dense network of scientific partnerships. These frequent coauthors include:

  • Martin Mayora Neto
  • George Carnell
  • Diego Cantoni
  • Jonathan L. Heeney
  • Kelly da Costa

Their extensive publication history and active collaborations reflect ongoing involvement in understanding viral pathogens, immune responses, and epidemiological patterns related to infectious diseases, especially in the context of the SARS-CoV-2 pandemic and influenza virus research.

Best Publications

  • A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

    Davide Corti;Jarrod Voss;Steven J. Gamblin;Giosiana Codoni

  • Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.

    Jeffrey Seow;Carl Graham;Blair Merrick;Sam Acors

  • SARS-CoV-2 evolution during treatment of chronic infection.

    Steven A. Kemp;Dami A. Collier;Dami A. Collier;Rawlings P. Datir;Isabella A. T. M. Ferreira

  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

    C Liu;H M Ginn;W Dejnirattisai;P Supasa

  • Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

    Dami A. Collier;Dami A. Collier;Anna De Marco;Isabella A. T. M. Ferreira;Bo Meng

  • Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

    Davide Corti;Amorsolo L. Suguitan;Debora Pinna;Chiara Silacci

  • T Cell Responses to Whole SARS Coronavirus in Humans

    Chris Ka Fai Li;Hao Wu;Huiping Yan;Shiwu Ma

  • The antigenic anatomy of SARS-CoV-2 receptor binding domain.

    Wanwisa Dejnirattisai;Daming Zhou;Helen M. Ginn;Helen M.E. Duyvesteyn

  • Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

    Jeffrey Seow;Carl Graham;Blair Merrick;Sam Acors

  • Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

    Unknown

  • Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.

    Vamsee V. A. Mallajosyula;Michael Citron;Francesca Ferrara;Xianghan Lu

  • Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules.

    Anna Hultberg;Nigel J. Temperton;Nigel J. Temperton;Valérie Rosseels;Mireille Koenders

  • Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.

    Emanuele Andreano;Emanuele Nicastri;Ida Paciello;Piero Pileri

  • Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi.

    Shane R. Wilkinson;Nigel J. Temperton;Angeles Mondragon;John M. Kelly

  • Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.

    Catherine J. Reynolds;Leo Swadling;Joseph M. Gibbons;Corinna Pade

  • Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation.

    S A Kemp;D A Collier;D A Collier;R Datir;R Datir;Iatm Ferreira

  • Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

    Nigel J. Temperton;Paul K. Chan;Graham Simmons;Maria C. Zambon

  • A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.

    Nigel J. Temperton;Katja Hoschler;Diane Major;Carolyn Nicolson

  • Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2

    Dami Collier;Anna De Marco;Isabella Ferreira;Bo Meng

  • ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

    Naif Khalaf Alharbi;Naif Khalaf Alharbi;Eriko Padron-Regalado;Craig P Thompson;Alexandra Kupke

  • ­­­The Antigenic Anatomy of SARS-CoV-2 Receptor Binding Domain

    Wanwisa Dejnirattisai;Daming Zhou;Helen M. Ginn;Helen Me Duyvesteyn

Frequent Co-Authors

Giovanni Cattoli
Giovanni Cattoli International Atomic Energy Agency
Robin A. Weiss
Robin A. Weiss University College London
Juthathip Mongkolsapaya
Juthathip Mongkolsapaya University of Oxford
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Teresa Lambe
Teresa Lambe University of Oxford
Sunetra Gupta
Sunetra Gupta University of Oxford
Ralf Wagner
Ralf Wagner University of Regensburg
Davide Corti
Davide Corti Vir Biotechnology (Switzerland)
Gavin R. Screaton
Gavin R. Screaton University of Oxford
Paul Kellam
Paul Kellam Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related online degrees that can enhance your career options. For those facing unique challenges, such as a criminal record, it’s encouraging to know there are still opportunities. Exploring what is the best degree for a convicted felon can help identify degrees that lead to stable careers despite past obstacles.

Healthcare is a dynamic field with multiple pathways. For example, becoming a Functional Medicine Nurse Practitioner merges traditional and holistic care approaches. Understanding the functional medicine nurse salary can provide insight into the financial benefits and motivate further education in this specialization.

Beyond direct patient care, careers in medical coding and health information management are growing. Earning a CPC certification can boost your prospects in medical coding, with competitive cpc certification salary opportunities. Similarly, a bachelor of science in health information management salary reflects promising earning potential for those managing healthcare data and systems.

These diverse online degrees complement a microbiology background and broaden career pathways in today’s evolving job market.

Best Scientists Citing Nigel J. Temperton

Trending Scientists

Recently Published Articles